Multiplex Assay Kit for NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay)

DHQU; DIA4; DTD; NMOR1; NMORI; QR1; Azoreductase; DT-diaphorase; Menadione reductase; Phylloquinone reductase; Quinone reductase 1; NAD(P)H:quinone oxidoreductase 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-101 90
EDTA plasma(n=5) 86-94 89
heparin plasma(n=5) 78-104 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-102% 78-92% 80-97% 97-105%
EDTA plasma(n=5) 90-99% 84-91% 78-103% 87-101%
heparin plasma(n=5) 88-101% 82-92% 80-89% 86-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:NQO1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Hypertension Transcription factor Nrf2 protects renal dopamine D1 receptor function during oxidative stress. Pubmed: 23876469
Free Radical Research Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: A novel mechanism of Nrf2/ARE signaling activation Informahealthcare: Source
physiological reports Antioxidant resveratrol restores renal sodium transport regulation in SHR PubMed: 26603454
Biol Chem Genetic association of NAD (P) H Quinone Oxidoreductase (NQO1* 2) polymorphism with NQO1 levels and risk of diabetic nephropathy Pubmed:27078674
Experimental Parasitology Sodium arsenite augments sensitivity of Echinococcus granulosus protoscoleces to albendazole Pubmed: 30790573
International Journal of Nanomedicine Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions Pubmed: 32764932
Exp Parasitol In vitro protoscolicidal effects of lithocholic acid on protoscoleces of Echinococcus granulosus and its mechanism Pubmed:35594934
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPL969Hu01 Recombinant NADH Dehydrogenase, Quinone 1 (NQO1) Positive Control; Immunogen; SDS-PAGE; WB.
APL969Hu01 Active NADH Dehydrogenase, Quinone 1 (NQO1) Cell culture; Activity Assays.
PAL969Hu01 Polyclonal Antibody to NADH Dehydrogenase, Quinone 1 (NQO1) WB; IHC; ICC; IP.
MAL969Hu21 Monoclonal Antibody to NADH Dehydrogenase, Quinone 1 (NQO1) WB; IHC; ICC; IP.
SEL969Hu ELISA Kit for NADH Dehydrogenase, Quinone 1 (NQO1) Enzyme-linked immunosorbent assay for Antigen Detection.
LML969Hu Multiplex Assay Kit for NADH Dehydrogenase, Quinone 1 (NQO1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.